T. Rowe Price Associates
YARW

T. Rowe Price Associates’s Yarrow Bioscience YARW Stock Holding History

T. Rowe Price Associates’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-21
Closed -$20K – 3021
2021
Q4 		$20K Hold
21
– – ﹤0.01% 2960
2021
Q3 		$27K Sell
21
-24
-53% -$46.5K ﹤0.01% 2927
2021
Q2 		$141K Buy
45
+9
+25% +$35.6K ﹤0.01% 2790
2021
Q1 		$222K Buy
+36
New +$261K ﹤0.01% 2659
2020
Q4 		– Sell
-3
Closed -$17K – 2721
2020
Q3 		$17K Buy
+3
New +$17.5K ﹤0.01% 2586
2020
Q1 		– Sell
-144
Closed -$2.4M – 2565
2019
Q4 		$2.4M Sell
144
-7
-5% -$117K ﹤0.01% 1553
2019
Q3 		$2.43M Sell
151
-15
-9% -$242K ﹤0.01% 1530
2019
Q2 		$3.58M Sell
166
-1
-0.6% -$24.7K ﹤0.01% 1442
2019
Q1 		$4.71M Buy
167
+1
+0.6% +$24K ﹤0.01% 1411
2018
Q4 		$2.47M Hold
166
– – ﹤0.01% 1512
2018
Q3 		$5.9M Buy
+166
New +$5.12M ﹤0.01% 1439

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

T. Rowe Price Associates's YARW Position: Q1 2022 in Review

T. Rowe Price Associates sold out of Yarrow Bioscience (YARW) in Q1 2022, closing a stake of 21 shares — an estimated $20K sold.

T. Rowe Price Associates first reported a position in YARW in Q3 2018 and held it in 11 quarters. The position peaked at $5.9M in Q3 2018. 41 funds tracked by Wall St. Rank hold YARW as of Q1 2022.

  • T. Rowe Price Associates reported no remaining Yarrow Bioscience position as of Q1 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 21 Yarrow Bioscience shares in Q1 2022, an estimated $20K.
  • T. Rowe Price Associates first reported a position in Yarrow Bioscience in Q3 2018 and held it in 11 quarters.
  • T. Rowe Price Associates's Yarrow Bioscience position peaked at $5.9M in Q3 2018.
  • 41 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2022.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.